September is Ovarian Cancer Awareness Month; ‘Exciting’ Advancements in Treating this Cancer Have Been Made in Recent Years September 13, 2021By Sydney Schaefer
Major Advance: PARP Inhibitor Pill Extends Life For Women With High Risk Breast Cancer & BRCA Mutations June 3, 2021By Alison Maxwell
PARP Inhibitors Keep Ovarian Cancer Under Control, But Women on These Drugs Need Support to ‘Set Them Up for Success’ September 23, 2020By Stephanie Watson
What Does a New Ovarian Cancer Drug Combo Approval Mean for Patients? August 12, 2020By Roxanne Nelson
